Ttbio Corp. (TPEX:6493)
40.15
-0.40 (-0.99%)
Aug 19, 2026, 10:29 AM CST
Ttbio Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 433.42 | 398.88 | 312.12 | 318.09 | 418.88 | 305.52 |
Revenue Growth | 8.66% | 27.80% | -1.88% | -24.06% | 37.11% | 70.72% |
Gross Profit Gross Profit Growth | 72.98 | 70.34 | 72.77 | 78.42 | 122.53 | 90.45 |
Operating Income Operating Income Growth | -23.01 | -21.23 | -2.29 | -0.86 | 38.36 | 12.26 |
Net Income Net Income Growth | -14.68 | -21.3 | 2.59 | 6.68 | 39.8 | 11.53 |
Earnings Per Share EPS Growth | -0.48 | -0.79 | 0.11 | 0.28 | 1.65 | 0.48 |
EPS Growth | - | - | -61.21% | -83.17% | 244.08% | -74.76% |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Remote Control Model Products Remote Control Model Products Growth | 13.41 | 13.78 |
Oral Healthcare Related Oral Healthcare Related Growth | 385.47 | 298.34 |
Total Total Growth | 398.88 | 312.12 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 92.15 | 53.75 | 82.6 | 59.36 | 113.05 | 70.1 |
Total Debt Total Debt Growth | 250.31 | 175.11 | 238.08 | 144.61 | 125.69 | 75.91 |
Net Cash (Debt) Net Cash Growth | -158.16 | -121.36 | -155.48 | -85.25 | -12.64 | -5.81 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.20 | -4.50 | -6.46 | -3.54 | -0.52 | -0.24 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -76.02 | -41.01 | 25.35 | 4 | 50.11 | 47.13 |
Capital Expenditures CapEx Growth | -12.27 | -8.01 | -6.88 | -41.85 | -36.6 | -14.76 |
Free Cash Flow Free Cash Flow Growth | -88.29 | -49.02 | 18.47 | -37.86 | 13.51 | 32.37 |
Free Cash Flow Growth | - | - | - | - | -58.26% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 16.84% | 17.63% | 23.32% | 24.65% | 29.25% | 29.61% |
Operating Margin | -5.31% | -5.32% | -0.73% | -0.27% | 9.16% | 4.01% |
Pretax Margin | -3.27% | -5.30% | 1.09% | 2.54% | 11.53% | 4.62% |
Profit Margin | -3.39% | -5.34% | 0.83% | 2.10% | 9.50% | 3.77% |
FCF Margin | -20.37% | -12.29% | 5.92% | -11.90% | 3.23% | 10.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.250 | - | 0.250 | 0.300 | 1.250 | 0.500 |
Dividend Per Share Growth | -33.31% | - | -16.67% | -76.00% | 150.00% | -75.00% |
Dividend Yield | 0.60% | - | 1.32% | 1.46% | 5.14% | 2.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 184.79 | 78.70 | 16.35 | 46.50 |
P/FCF Ratio | - | - | 25.92 | - | 48.15 | 16.57 |
PS Ratio | 2.67 | 2.04 | 1.53 | 1.65 | 1.55 | 1.76 |